Vol. 10, Issue 1 (2024)

Background: The approach to treating recurrent traumatic anterior glenohumeral instability has been debated for many years. Both the Latarjet and Eden methods have been discussed extensively in this context. Hybinette are golden modalities in treating t of recurrent shoulder dislocation with bone loss.
Aim of the work: To evaluate the efficacy of Latarjet vs free tricortical iliac graft in treating recurrent shoulder dislocations caused by glenoid bone loss or Hill Sachs lesions of the humeral head. 
Patients and Methods: This study is a prospective randomized controlled trial (RCT), it was performed on forty adult patients suffering from recurrent shoulder dislocations with losing of bone. The patients were assigned at random into 2 separate groups. (Twenty Eden Hybinette cases and twenty Latarjet controls). We compared the reaults both clinically using modified Rowe score and radiologically using CT at least six months. Also possible complications of both groups were documented.
Results: There was no statistically substantial difference among both groups clinically and radiologically (p> .05). Except more limited ROM (especially both external and internal rotation) in Latarjet group at final follow-up (p< .05). One case in group of latarjet had recurrent dislocation due to tramadol fits. 2 cases in each group had anterior apprehension only. Ten percent of the Eden group showed signs of donor-site sensory abnormalities. The iliac group had a greater graft size, as seen by CT. 
Conclusion: Both Latarjet and Eden Hybinette are competing modalities for restoring shoulder stability with bone loss, Although Eden Hybinette had a better ROM.